Clearside Biomedical (CLSD) Form 4 Clearside Biomedical / Clay Thorp ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hatteras Venture Advisors III, LLC

(Last) (First) (Middle)

280 S. MANGUM STREET, SUITE 350

(Street)

DURHAM NC 27701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clearside Biomedical, Inc. [ CLSD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)	X	Other (specify below)
May be part of a 13(d) Group

3. Date of Earliest Transaction (Month/Day/Year)
01/17/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/17/2017		S		8,366	D	$8.92(1)	1,774,654	I	See Footnote(2)
Common Stock	01/18/2017		S		10,457	D	$8.64(3)	1,764,197	I	See Footnote(2)
Common Stock	01/19/2017		S		6,478	D	$8.22(4)	1,757,719	I	See Footnote(2)(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Hatteras Venture Advisors III, LLC

(Last) (First) (Middle)

280 S. MANGUM STREET, SUITE 350

(Street)

DURHAM NC 27701

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Hatteras Ventures Partners III LP

(Last) (First) (Middle)

280 S. MANGUM STREET, SUITE 350

(Street)

DURHAM NC 27701

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Hatteras Venture Affiliates III Lp

(Last) (First) (Middle)

280 S. MANGUM STREET, SUITE 350

(Street)

DURHAM NC 27701

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Crumpler John

(Last) (First) (Middle)

C/O HATTERAS VENTURES

280 S. MANGUM STREET, SUITE 350

(Street)

DURHAM NC 27701

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

INGRAM ROBERT ALEXANDER

(Last) (First) (Middle)

C/O HATTERAS VENTURES

280 S. MANGUM STREET, SUITE 350

(Street)

DURHAM NC 27701

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

LEE KENNETH B JR

(Last) (First) (Middle)

C/O HATTERAS VENTURES

280 S. MANGUM STREET, SUITE 350

(Street)

DURHAM NC 27701

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Reed Douglas MD

(Last) (First) (Middle)

C/O HATTERAS VENTURES

280 S. MANGUM STREET, SUITE 350

(Street)

DURHAM NC 27701

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Thorp Clay

(Last) (First) (Middle)

C/O HATTERAS VENTURES

280 S. MANGUM STREET, SUITE 350

(Street)

DURHAM NC 27701

(City) (State) (Zip)

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $8.68 to $9.22. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

2. The reportable securities are owned directly by Hatteras Venture Partners III, LP ("HVP") and Hatteras Venture Affiliates III, LP ("HVA"). Hatteras Venture Advisors III, LLC is the general partner of HVP and HVA (the "GP"). The shares directly held by HVP and HVA are indirectly held by the individual managing members of GP (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP and HVA. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.

3. This transaction was executed in multiple trades at prices ranging from $8.42 to $8.79. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

4. This transaction was executed in multiple trades at prices ranging from $8.01 to $8.65. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

5. HVP holds 1,611,407 shares and HVA holds 146,312 shares of the Issuer's common stock directly.

	/s/ Thomas A. Allen, attorney-in-fact for Hatteras Venture Advisors III, LLC	01/19/2017
	/s/ Thomas A. Allen, attorney-in-fact for Hatteras Venture Advisors III, LLC, the general partner of Hatteras Venture Partners III, LP	01/19/2017
	/s/ Thomas A. Allen, attorney-in-fact for Hatteras Venture Advisors III, LLC, the general partner of Hatteras Venture Affiliates III, LP	01/19/2017
	/s/ Thomas A. Allen, attorney-in-fact for John C. Crumpler	01/19/2017
	/s/ Thomas A. Allen, attorney-in-fact for Robert A. Ingram	01/19/2017
	/s/ Thomas A. Allen, attorney-in-fact for Kenneth B. Lee	01/19/2017
	/s/ Thomas A. Allen, attorney-in-fact for Douglas Reed	01/19/2017
	/s/ Thomas A. Allen, attorney-in-fact for Clay B. Thorp	01/19/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.